Octopus Ventures led the seed financing, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital, to commercialise live cell imaging technology.
CellVoyant
CellVoyant is a biotechnology company developing artificial intelligence platforms to advance novel stem cell therapies.
CellVoyant is an artificial intelligence driven biotechnology company that accelerates the development of novel stem cell therapies. The business combines advanced live cell imaging with proprietary technology to predict stem cell behaviour.
Filed accounts
Cash at bank
Net current assets
Total assets less current liabilities
Shareholders' funds
Fixed assets
Current assets
Cash, assets and headcount from CellVoyant's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Founders
Rafael Carazo Salas
CEO and founder
Rafael brings academic research and founding experience from the University of Bristol and CellVoyant. He previously held research and leadership roles at the University of Cambridge, The Alan Turing Institute, and Adrestia Therapeutics.
LinkedIn

